For example, in glioblastoma-initiating cancer cells isolated from patients, RES in the doses of 5, 10 and 20 μM inhibited the invasion of these cells via downregulation of the PI3K/AKT/NF-κB signaling pathway in vitro and in vivo [85]. This evidence concerns the gene AKT1 and cancer.